Detection of IDH1 and IDH2 Mutations by Fluorescence Melting Curve Analysis as a Diagnostic Tool for Brain Biopsies
- 1 July 2010
- journal article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 12 (4) , 487-492
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01 88041)
This publication has 20 references indexed in Scilit:
- Characterization of R132H Mutation‐specific IDH1 Antibody Binding in Brain TumorsBrain Pathology, 2009
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1αScience, 2009
- Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancersInternational Journal of Cancer, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- Metabolic Enzymes as Oncogenes or Tumor SuppressorsNew England Journal of Medicine, 2009
- IDH1mutations at residue p.R132 (IDH1R132) occur frequently in high-grade gliomas but not in other solid tumorsHuman Mutation, 2008
- Analysis of the IDH1 codon 132 mutation in brain tumorsActa Neuropathologica, 2008
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomasCancer Letters, 2004
- Multiplex PCR by multicolor fluorimetry and fluorescence melting curve analysisNature Medicine, 2001